Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Korea, republic of
  4. Korea Stock Exchange
  5. Celltrion, Inc.
  6. News
  7. Summary
    A068270   KR7068270008

CELLTRION, INC.

(A068270)
  Report
End-of-day quote Korea Stock Exchange  -  2022-10-04
171500.00 KRW   -0.87%
09/28Celltrion's Oncology Drug Gets Marketing Authorization in Japan
MT
09/28S.Korean shares, won tumble on recession fears
RE
09/22Celltrion, Abpro Partner to Develop, Commercialize Breast Cancer Treatment Drug
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Celltrion's Net Income Jumps 41.2% in June Quarter

08/07/2022 | 08:25pm EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
CELLTRION, INC. -0.87% 171500 End-of-day quote.-13.38%
KOSPI COMPOSITE INDEX 1.02% 2237.86 Real-time Quote.-25.58%
All news about CELLTRION, INC.
09/28Celltrion's Oncology Drug Gets Marketing Authorization in Japan
MT
09/28S.Korean shares, won tumble on recession fears
RE
09/22Celltrion, Abpro Partner to Develop, Commercialize Breast Cancer Treatment Drug
MT
09/19Britain’s MHRA Clears Celltrion's Cancer Drug Vegzelma for Marketing in the UK
MT
09/06PTAB Institutes IPRs Of Tocilzumab Patents Challenged By Celltrion
AQ
09/05S.Korean shares end at over six-week low on Europe energy worries
RE
08/16Celltrion, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended Ju..
CI
08/15Infliximab Clinical Trial Updates
AQ
08/09Celltrion Files IND With FDA For Adalimumab Biosimilar
AQ
08/07Celltrion's Net Income Jumps 41.2% in June Quarter
MT
More news
Financials
Sales 2022 2 329 B 1,64 B 1,64 B
Net income 2022 620 B 0,44 B 0,44 B
Net cash 2022 746 B 0,52 B 0,52 B
P/E ratio 2022 38,3x
Yield 2022 0,27%
Capitalization 23 422 B 16 476 M 16 476 M
EV / Sales 2022 9,74x
EV / Sales 2023 8,74x
Nbr of Employees 2 034
Free-Float 74,8%
Chart CELLTRION, INC.
Duration : Period :
Celltrion, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CELLTRION, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Last Close Price 170 000,00 KRW
Average target price 221 000,00 KRW
Spread / Average Target 30,0%
EPS Revisions
Managers and Directors
Wu-Sung Ki Chief Executive Officer & Director
Ho-Seop Lee Finance Director
Jung-Jin Seo Chairman
Sung-Han Lee Head-Legal & Compliance Support
Dong-Il Kim Independent Director
Sector and Competitors
1st jan.Capi. (M$)
CELLTRION, INC.-13.38%16 621
MODERNA, INC.-50.54%49 142
LONZA GROUP AG-33.72%38 001
IQVIA HOLDINGS INC.-31.78%35 901
SEAGEN INC.-11.47%25 244
ALNYLAM PHARMACEUTICALS, INC.18.67%24 128